EP3253797A4 - Chemokin-immunoglobulin-fusionspolypeptide, zusammensetzungen daraus, verfahren zur herstellung und verwendung davon - Google Patents

Chemokin-immunoglobulin-fusionspolypeptide, zusammensetzungen daraus, verfahren zur herstellung und verwendung davon Download PDF

Info

Publication number
EP3253797A4
EP3253797A4 EP16747125.9A EP16747125A EP3253797A4 EP 3253797 A4 EP3253797 A4 EP 3253797A4 EP 16747125 A EP16747125 A EP 16747125A EP 3253797 A4 EP3253797 A4 EP 3253797A4
Authority
EP
European Patent Office
Prior art keywords
chemokine
compositions
making
fusion polypeptides
immunoglobulin fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16747125.9A
Other languages
English (en)
French (fr)
Other versions
EP3253797A1 (de
Inventor
James W. Lillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jyant Technologies Inc
Original Assignee
Jyant Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/612,884 external-priority patent/US9249204B2/en
Application filed by Jyant Technologies Inc filed Critical Jyant Technologies Inc
Publication of EP3253797A1 publication Critical patent/EP3253797A1/de
Publication of EP3253797A4 publication Critical patent/EP3253797A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP16747125.9A 2015-02-03 2016-02-02 Chemokin-immunoglobulin-fusionspolypeptide, zusammensetzungen daraus, verfahren zur herstellung und verwendung davon Withdrawn EP3253797A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/612,884 US9249204B2 (en) 2011-06-01 2015-02-03 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
PCT/US2016/016191 WO2016126719A1 (en) 2015-02-03 2016-02-02 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Publications (2)

Publication Number Publication Date
EP3253797A1 EP3253797A1 (de) 2017-12-13
EP3253797A4 true EP3253797A4 (de) 2018-10-03

Family

ID=56564605

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16747125.9A Withdrawn EP3253797A4 (de) 2015-02-03 2016-02-02 Chemokin-immunoglobulin-fusionspolypeptide, zusammensetzungen daraus, verfahren zur herstellung und verwendung davon

Country Status (3)

Country Link
EP (1) EP3253797A4 (de)
CN (1) CN107207603A (de)
WO (1) WO2016126719A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111886241A (zh) * 2018-01-09 2020-11-03 库尔生物制药有限公司 多聚体t细胞调节多肽及其使用方法
CN113840832A (zh) * 2018-05-14 2021-12-24 狼人治疗公司 可活化白介素-2多肽及其使用方法
JP2021523743A (ja) * 2018-05-15 2021-09-09 カースゲン セラピューティクス カンパニー リミテッドＣａｒｓｇｅｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｏ．， Ｌｔｄ． 遺伝子操作された細胞及びその応用
CA3147677A1 (en) * 2019-08-13 2021-02-18 Elpis Biopharmaceuticals Engineered interleukin-2 receptor beta agonists
CN111440244B (zh) * 2020-04-09 2021-03-16 诺未科技（北京）有限公司 靶向vegfr2的转移性癌疫苗
EP4168431A4 (de) * 2020-06-21 2024-04-10 Technion Research & Development Foundation Limited Modifiziertes cxcl10 für die immuntherapie von krebserkrankungen
EP4168432A4 (de) * 2020-06-21 2024-04-17 Technion Research & Development Foundation Limited Cxcl9 und varianten davon zur immuntherapie von krebserkrankungen
CN116322740A (zh) * 2020-07-13 2023-06-23 特兰斯吉恩股份有限公司 免疫抑制的治疗
CN113318120A (zh) * 2021-06-07 2021-08-31 昆明医科大学第二附属医院 一种miR4512及CXCL2在自身免疫性疾病中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037305A1 (en) * 2003-10-16 2005-04-28 Applied Research Systems Ars Holding N.V. Therapeutic uses of chemokine variants
US20070036750A1 (en) * 2005-08-12 2007-02-15 Schering Corporation MCP1 fusions
US20100196406A1 (en) * 2007-06-04 2010-08-05 Rappaport Family Institute For Research In The Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
US20120308565A1 (en) * 2011-06-01 2012-12-06 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130323245A1 (en) * 2011-06-01 2013-12-05 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
CN101094688B (zh) * 2004-09-13 2013-05-01 建新公司 多聚构建体
GB0605735D0 (en) * 2006-03-22 2006-05-03 Immunobiology Ltd Composition and method for mediating an immune response

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037305A1 (en) * 2003-10-16 2005-04-28 Applied Research Systems Ars Holding N.V. Therapeutic uses of chemokine variants
US20070036750A1 (en) * 2005-08-12 2007-02-15 Schering Corporation MCP1 fusions
US20100196406A1 (en) * 2007-06-04 2010-08-05 Rappaport Family Institute For Research In The Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
US20120308565A1 (en) * 2011-06-01 2012-12-06 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130323245A1 (en) * 2011-06-01 2013-12-05 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130330337A1 (en) * 2011-06-01 2013-12-12 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016126719A1 *

Also Published As

Publication number Publication date
CN107207603A (zh) 2017-09-26
WO2016126719A1 (en) 2016-08-11
EP3253797A1 (de) 2017-12-13

Similar Documents

Publication Publication Date Title
IL257030A (en) Multivalent and multispecific cleavage proteins that bind to gitr Preparations containing them and uses thereof
EP3347472A4 (de) Zusammensetzungen mit cyp76ad1-clade-polypeptiden und verwendungen davon
EP3298033A4 (de) Zusammensetzungen und verfahren für tcr-programmierung mit fusionsproteinen
EP3104865A4 (de) Mikro-organoide und verfahren zur herstellung und verwendung davon
EP3166892A4 (de) Kesselsteinhemmungszusammensetzungen sowie verfahren zur herstellung und verwendung davon
IL275435A (en) TATK – CDKL5 fusion proteins, preparations, formulations, and their uses
EP3354653A4 (de) Kondensierte ringpyrimidinverbindung, zwischenprodukt und herstellungsverfahren, zusammensetzung und verwendung davon
EP3703676A4 (de) Zusammensetzung und verfahren zur modifizierung von polypeptiden
EP3136879A4 (de) Konzentrierte proteinzusammensetzungen und verfahren zu deren herstellung
EP3092248A4 (de) Fusionspolypeptide und verfahren zur verwendung
EP3170808A4 (de) Polythiolzusammensetzung und verfahren zur herstellung davon
EP3270985A4 (de) Polypeptidzusammensetzungen und verfahren zur verwendung davon
EP3237452A4 (de) Fusionsproteine und verfahren dafür
EP3202775A4 (de) Conotoxinpolypeptid-kappa-cptx-bt104 und verfahren zur herstellung davon und anwendung davon
EP3323825A4 (de) Polypeptidverbindung und herstellungsverfahren und verwendung davon
EP3315508A4 (de) Polypeptidverbindung und herstellungsverfahren und verwendung davon
EP3269725A4 (de) Verfahren zur herstellung einer proteinzusammensetzung und proteinzusammensetzung
EP3146968A4 (de) K2-zusammensetzung, herstellungsverfahren dafür und anwendung davon
EP3202778A4 (de) Conotoxinpolypeptid kappa-cptx-bt105 und verfahren zur herstellung davon und anwendung davon
EP3081581A4 (de) Diazoresin, fotolackzusammensetzung und verfahren zur herstellung einer fotolackzusammensetzung
EP3392263A4 (de) Polypeptidverbindung, herstellungsverfahren dafür und verwendung davon
EP3394174A4 (de) Zusammensetzung, verfahren zur herstellung der zusammensetzung und artikel
EP3132790A4 (de) Exenatidhaltige zusammensetzung und herstellungsverfahren dafür
EP3136864A4 (de) Zusammensetzungen, verfahren zur herstellung einer zusammensetzung und verfahren zur verwendung
GB201715817D0 (en) Methods, compositions and uses relating thereto

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170629

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/28 20060101AFI20180524BHEP

Ipc: A61K 39/395 20060101ALI20180524BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20180904

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/28 20060101AFI20180829BHEP

Ipc: A61K 39/395 20060101ALI20180829BHEP

17Q First examination report despatched

Effective date: 20200203

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200616